Small dense low-density lipoprotein-lowering agents
- 19 May 2020
- journal article
- review article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 401 (10) , 1101-1121
Abstract
Metabolic disorders, including obesity, diabetes, and hyperlipidemia, as well as cardiovascular diseases (CVD), particularly atherosclerosis, are still leading causes of death worldwide. Plasma levels of low-density lipoprotein (LDL) are currently being considered as a critical risk factor for the diseases mentioned above, especially atherosclerosis. Because of the heterogeneous nature of LDL, many studies have already been conducted on its subclasses, especially small dense LDL (sdLDL). According to available evidence, sdLDL levels can be considered as an ideal alternative to LDL levels for monitoring CVD and early diagnosis of atherosclerosis. Recently, several researchers have focused on factors that are able to decrease sdLDL levels and improve health quality. Therefore, the purpose of this study is to describe the production process of sdLDL particles and review the effects of pharmaceutical and dietary agents as well as lifestyle on sdLDL plasma levels. In brief, their mechanisms of action are discussed. Apparently, cholesterol and LDL-lowering compounds are also effective in the reduction of sdLDL levels. In addition, improving lipid profile, especially the reduction of triglyceride levels, appropriate regimen, and lifestyle can decrease sdLDL levels. Therefore, all the aforementioned parameters should be taken into consideration simultaneously in sdLDL levels reducing strategies.Keywords
This publication has 176 references indexed in Scilit:
- Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetesLipids in Health and Disease, 2013
- Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapibJournal of Lipid Research, 2012
- N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegansNature, 2011
- Role of nutraceuticals in human healthJournal of Food Science and Technology, 2011
- Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adultsLipids in Health and Disease, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locusNature, 2010
- Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated andNpc1l1−/−miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Docosahexaenoic acid (DHA) and hepatic gene transcriptionChemistry and Physics of Lipids, 2008
- A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority studyDiabetologia, 2006